Clare L Cutland

Summary

Affiliation: University of the Witwatersrand/Medical Research Council
Country: South Africa

Publications

  1. ncbi Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial
    Clare L Cutland
    Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases and Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of Witwatersrand, Soweto, South Africa
    Lancet 374:1909-16. 2009
  2. ncbi Maternal HIV infection and vertical transmission of pathogenic bacteria
    Clare L Cutland
    Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases and Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Soweto, South Africa
    Pediatrics 130:e581-90. 2012
  3. ncbi Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads
    Mashudu Madzivhandila
    Vaccine Preventable Diseases and Respiratory and Meningeal Pathogens Research Unit, Department of Science and Technology National Research Foundation, University of Witwatersrand, Johannesburg, South Africa
    PLoS ONE 6:e17861. 2011
  4. ncbi Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety
    Shabir A Madhi
    Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases, University of Witwatersrand, South Africa
    Clin Infect Dis 52:128-37. 2011

Detail Information

Publications4

  1. ncbi Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial
    Clare L Cutland
    Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases and Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of Witwatersrand, Soweto, South Africa
    Lancet 374:1909-16. 2009
    ..We therefore assessed the efficacy of chlorhexidine in early-onset neonatal sepsis and vertical transmission of group B streptococcus...
  2. ncbi Maternal HIV infection and vertical transmission of pathogenic bacteria
    Clare L Cutland
    Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases and Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Soweto, South Africa
    Pediatrics 130:e581-90. 2012
    ..HIV-exposed newborns may be at higher risk of sepsis because of immune system aberrations, impaired maternal antibody transfer and altered exposure to pathogenic bacteria...
  3. ncbi Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads
    Mashudu Madzivhandila
    Vaccine Preventable Diseases and Respiratory and Meningeal Pathogens Research Unit, Department of Science and Technology National Research Foundation, University of Witwatersrand, Johannesburg, South Africa
    PLoS ONE 6:e17861. 2011
    ..An understanding of the serotype epidemiology associated with maternal colonization and invasive disease in infants is necessary to determine the potential coverage of serotype-specific GBS vaccines...
  4. ncbi Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety
    Shabir A Madhi
    Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases, University of Witwatersrand, South Africa
    Clin Infect Dis 52:128-37. 2011
    ..Data on the efficacy of trivalent, inactivated influenza vaccine (TIV) in HIV-infected adults, particularly in Africa, are limited. This study evaluated the safety, immunogenicity, and efficacy of TIV in HIV-infected adults...